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Abstract
Background: Telomerase is a reverse transcriptase that maintains the telomeres of linear chromosomes and preserves
genomic integrity. The core components are a catalytic protein subunit, the telomerase reverse transcriptase (TERT), and an
RNA subunit, the telomerase RNA (TR). Telomerase is unique in its ability to catalyze processive DNA synthesis, which is
facilitated by telomere-specific DNA-binding domains in TERT called anchor sites. A conserved glutamine residue in the
TERT N-terminus is important for anchor site interactions in lower eukaryotes. The significance of this residue in higher
eukaryotes, however, has not been investigated.
Methodology/Principal Findings: To understand the significance of this residue in higher eukaryotes, we performed site-
directed mutagenesis on human TERT (hTERT) Q169 to create neutral (Q169A), conservative (Q169N), and non-conservative
(Q169D) mutant proteins. We show that these mutations severely compromise telomerase activity in vitro and in vivo. The
functional defects are not due to abrogated interactions with hTR or telomeric ssDNA. However, substitution of hTERT Q169
dramatically impaired the ability of telomerase to incorporate nucleotides at the second position of the template.
Furthermore, Q169 mutagenesis altered the relative strength of hTERT-telomeric ssDNA interactions, which identifies Q169
as a novel residue in hTERT required for optimal primer binding. Proteolysis experiments indicate that Q169 substitution
alters the protease-sensitivity of the hTERT N-terminus, indicating that a conformational change in this region of hTERT is
likely critical for catalytic function.
Conclusions/Significance: We provide the first detailed evidence regarding the biochemical and cellular roles of an
evolutionarily-conserved Gln residue in higher eukaryotes. Collectively, our results indicate that Q169 is needed to maintain
the hTERT N-terminus in a conformation that is necessary for optimal enzyme-primer interactions and nucleotide
incorporation. We show that Q169 is critical for the structure and function of human telomerase, thereby identifying a novel
residue in hTERT that may be amenable to therapeutic intervention.
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Introduction
Telomeres are DNA-protein structures that define the ends of
linear chromosomes and form a protective ‘cap’ that enables cells
to maintain chromosome length and stability by preventing
telomere degradation, recombination, and end-to-end fusions
(reviewed in [1,2]). The proper maintenance of telomere structure
and function is crucial for prolonged cell proliferation and genome
stability [3]. Indeed, one hallmark of human cancer cells is the up-
regulation of telomere maintenance mechanisms that prevent
telomere shortening and confer unlimited replicative capacity. In
normal cells, however, the inability of conventional DNA
polymerases to fully replicate the ends of linear chromosomes
results in telomere erosion during cell division [4,5,6,7]. Most
eukaryotes utilize an enzyme called telomerase to synthesize and
maintain telomeric DNA. Telomerase is a ribonucleoprotein
(RNP) reverse transcriptase (RT) complex that minimally contains
a catalytic protein subunit, the telomerase reverse transcriptase
(TERT), and an RNA subunit, the telomerase RNA (TR) [8,9,10].
TERT uses a small RNA template within TR to reverse transcribe
telomeric nucleotides onto the ss 39-ends of chromosomes in vivo or
G-rich oligonucleotides in vitro (reviewed in [11,12]). TERT
proteins are structurally defined by conserved RT and telomerase-
specific domains [11]. As illustrated in Figure 1, the structural
organization of TERT can be divided into at least three modular
regions: 1) a long N-terminal extension (NTE) that contains
conserved domains and an unstructured linker region, 2) a central
catalytic RT domain with seven evolutionarily-conserved RT
motifs, and 3) a short C-terminal extension (CTE) [11,13]. TERT-
specific domains in the NTE and CTE contribute to the
biochemical properties that distinguish telomerase from prototyp-
ical RT’s [11].
Genetic and somatic mutations that disrupt the normal
assembly and function of the human telomerase RNP are
associated with a spectrum of disease states [14]. The physiological
importance of telomerase is further illustrated by the fact that at
least 85% of human cancers exhibit up-regulated telomerase
activity, which prevents telomere shortening and confers these cells
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therapeutics that can modulate telomerase activity in vivo.
Unfortunately, the applicability of current therapies is limited
because the molecular mechanism(s) that regulate the assembly
and activity of human telomerase are poorly understood. Thus,
structure-function studies of human telomerase are necessary for
the rationale design of novel telomerase inhibitors.
Functional human telomerase can be reconstituted in rabbit
reticulocytelysates (RRL)byco-expressing humanTERT(hTERT)
and TR (hTR) [15,16], although additional proteins are required
for telomerase assembly, activity, and regulation in vivo
[17,18,19,20,21]. A unique attribute of telomerase is its ability to
processively synthesize telomeric repeats (repeat addition processiv-
ity) [8,22,23]. Telomerase recognizes, binds, and correctly orien-
tates the telomeric DNA primer in the active site to initiate reverse
transcription. TERT subsequently copies the TR template, one
nucleotide (nt) at a time, until reaching the template 59-boundary
region. At this point, the position of the RT active site relative to the
nascent DNA 39-end must be reset to initiate the next round of
telomere synthesis [11]. An important requisite of processive repeat
synthesis is that telomerase remains bound to the telomere during
the entire reaction cycle. TERT contains template-independent
DNA-binding regions outside the RT domain, known as anchor
sites,thatinteractwithprimerntupstreamofthe RNA-DNAhybrid
[24,25,26,27]. Anchor site interactions are thought to confer repeat
addition processivity by anchoring telomerase to the telomere and
preventing dissociation during translocation when the RNA-DNA
hybrid in the active site is separated [11].
A telomerase anchor region has been physically and functionally
mapped to the TERT N-terminus in ciliates, yeast, and humans
[11,28,29,30,31,32]. The structure of an N-terminal domain of
Tetrahymena TERT, known as the conserved TERT essential N-
terminal (TEN) domain, has been determined by X-ray crystallog-
raphy [33]. Conserved residues on the surface of this domain are
predicted to form a previously unrecognized ssDNA-binding channel
[33]. Photo-cross-linking studies have shown that the Tetrahymena
TERT (tTERT) TEN domain binds telomeric ssDNA [30,33].
Mutagenesis of key residues thought to be involved in ssDNA-
binding, such as an invariant Gln (Q168 in tTERT), significantly
reduced the interaction between tTERT and telomeric ssDNA and
impaired enzyme activity in vitro [30,33]. Furthermore, mutation of
the corresponding residue in Saccharomyces cerevisiae TERT (Est2p
Q146A) severely impaired telomerase activity and caused growth
defects and telomere loss in vivo [31]. It is thought that this Gln is
important for telomeric primer recognition and orientation in the
c a t a l y t i csi t et oi n it ia t et e lo m e r es y n t h e s is[ 3 0 , 3 3 ] .T h eco n t r i b u t i o no f
this residue to telomerase structure and function in higher eukaryotes,
however, has not been investigated.
In this study, we aimed to determine if the evolutionarily-
conserved Gln was important for telomerase function in higher
eukaryotes and therefore, characterized the corresponding residue
in human TERT (Q169). Site-directed mutagenesis was used to
create neutral (Q169A), conservative (Q169N), and non-conser-
vative (Q169D) mutant hTERT proteins. Human telomerase
reconstituted with hTERT Q169A, Q169D, or Q169N exhibited
severely reduced levels of DNA synthesis in vitro and hTERT
Q169A failed to catalyze telomere elongation in vivo. Substitution
of hTERT Q169 dramatically impaired the ability of human
telomerase to incorporate nucleotides at the second position of the
template. Mutation of Q169 did not abrogate the ability of
hTERT to interact with hTR or telomeric ssDNA. When
compared to wild type hTERT, however, the Q169 mutants
exhibited subtle differences in the relative strength of the
interaction with telomeric ssDNA, thereby elucidating a role for
Q169 in protein-DNA interactions. Limited proteolysis experi-
ments indicate that the Q169 substitutions altered the protease-
sensitivity of the hTERT N-terminus, revealing the importance of
conformational changes in this region of hTERT for enzyme
activity. We show that the conserved Gln is a functionally critical
residue in human telomerase and provide the first detailed
evidence regarding the biochemical and cellular significance of
this residue in higher eukaryotes.
Materials and Methods
Oligonucleotides
All oligonucleotides were synthesized by University Core DNA
Services (University of Calgary, Calgary, AB). The oligonucleotide
sequences, written 59 to 39, are listed in Table 1. Unless otherwise
Figure 1. Linear representation of hTERT. The conserved catalytic
reverse transcriptase (RT) domain is depicted with a light grey box, the
black box represents the conserved telomerase-specific (TS) motif,
white boxes depict the N- and RT-primer grip regions and the black
circle signifies the approximate location of Q169. The schematics below
indicate the predicted locations of RNA-interacting domains 1 and 2
(RID 1 and RID 2, respectively) and the TERT essential N-terminal (TEN)
domain. NTE: N-terminal extension and CTE: C-terminal extension.
doi:10.1371/journal.pone.0007176.g001
Table 1. Description of the ssDNA primers used in the primer
binding and conventional telomerase activity assays.
Primer Length Biotin Sequence
bio-TELO30 30 Yes TTAGGG TTAGGG TTAGGG TTAGGG
TTAGGG
bio-TELO24 24 Yes TTAGGG TTAGGG TTAGGG TTAGGG
bio-TELO18 18 Yes TTAGGG TTAGGG TTAGGG
bio-TELO12 12 Yes TTAGGG TTAGGG
bio-TELO6 6 Yes TTAGGG
bio-antiTELO18 18 Yes AATCCC AATCCC AATCCC
bio-pBR 24 Yes AGCCAC TATCGA CTACGC GATCAT
bio-BBP 24 Yes AATCCG TCGAGC AGAAAT CCGCAA
bio-Tetrahymena 18 Yes TTGGGG TTGGGG TTGGGG
bio-Yeast 15 Yes TGTGTG GTGTGT GGG
TELO24 24 No TTAGGG TTAGGG TTAGGG TTAGGG
TELO18 18 No TTAGGG TTAGGG TTAGGG
Primer, oligonucleotide name; Length, number of nucleotides; Biotin, whether
the primer is 59-biotinylated; Sequence, the 59 to 39 nucleotide sequence.
doi:10.1371/journal.pone.0007176.t001
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conventional telomerase activity assays contain biotin at the 59-
end. The oligonucleotides used in the telomere repeat amplifica-
tion protocol and terminal restriction fragment analysis do not
contain biotin tags.
hTERT constructs
hTERT constructs were cloned using site-directed mutagenesis.
Each construct contained an N-terminal EcoRI restriction site and
FLAG epitope, and a C-terminal SalI restriction site. The identity
of each hTERT construct was confirmed by EcoRI-SalI digestion,
DNA sequencing, and in vitro expression of [
35S]cysteine-labelled
hTERT.
Synthesis and purification of hTR
The full length human telomerase RNA spanning nt 1 to 451,
was cloned as described previously [34], and synthesized in vitro
using the MEGAscript T7 transcription kit (Ambion, CedarlaneH
Laboratories Ltd.) as detailed in [28].
In vitro reconstitution of human telomerase
hTR was cloned and synthesized as described previously
[28,34]. Human telomerase was reconstituted in vitro with the
rabbit reticulocyte lysate (RRL) TNT
H T7 Transcription-Trans-
lation System (Promega, Fisher Scientific Ltd.), according to the
manufacturer’s instructions. Final reaction volumes containing the
appropriate hTERT plasmid DNA (10 ng/mL) and full length in
vitro-transcribed hTR (10 ng/mL) were incubated at 30uC for 90 or
120 min.
Cell lines and culture conditions
Simian immunodeficiency virus 40 (SV40) large T-antigen
transformed human embryonic kidney cells (293T) were cultured
in GIBCO
H high glucose Dulbecco’s Modified Eagle’s Media
(DMEM) supplemented with 10% fetal bovine serum, 50 U/mL
penicillin G, and 50 mg/mL streptomycin sulfate (Invitrogen).
1 mg/mL puromycin (Sigma-Aldrich) was added to the growth
media for stable 293T cell lines. 293T cells were continuously
passaged at 1:5 or 1:6.
Primary human foreskin fibroblasts (BJ cells) were cultured in
Lonza BioWhittaker* Minimum Essential Medium Eagle (EMEM)
with EBSS (Fischer Scientific Ltd.) supplemented with L-
glutamine, 10% fetal bovine serum, 50 U/mL penicillin G, and
50 mg/mL streptomycin sulfate (Invitrogen). Stable cell lines were
cultured in media containing 0.1–0.5 mg/mL puromycin (Sigma-
Aldrich). BJ cells were passaged at 1:4 or 1:5 until the culture
divided 2.5 times more than the vector control cells or until the
culture had exhausted its replicative potential. This stage was
defined as the period when cultures failed to become confluent
within 30 days and stained positive for b-galactosidase at pH 6.0.
Cell transfections and retroviral infections
293T cells were stably transfected with 1 mg of pBABEpuro,
pBABEpuro-FLAG-hTERT WT, or pBABEpuro-FLAG-hTERT
Q169A DNA using FuGENE transfection reagent (Roche).
Transfected cultures were split into selective media containing
1.0 mg/mL puromycin (Sigma-Aldrich) 48 h post-transfection.
The first plate to reach confluence under selection was arbitrarily
defined as mean population doubling (mpd) 0.
Retroviral infections were used to establish polyclonal BJ cell
lines that stably expressed pBABEpuro, pBABEpuro-FLAG-hTERT
WT, or pBABEpuro-FLAG-hTERT Q169A. 293T cells were used
to package amphotropic retroviruses created with the helper
plasmid pCL-10A1 and pBABEpuro, pBABEpuro-FLAG-hTERT
WT, or pBABEpuro-FLAG-hTERT Q169A plasmid DNA. 293T
cells were transiently transfected with the appropriate construct
DNA using FuGENE transfection reagent (Roche). The viral
supernatant was collected 24 h after transfection, filtered,
supplemented with polybrene (Sigma-Aldrich) to a final concen-
tration of 8 mg/mL, and applied to BJ cells. 48 h after retroviral
infection, BJ cells were split 1:4 with selective media containing
0.1–0.5 mg/mL puromycin (Sigma-Aldrich). Mean population
doubling 0 was arbitrarily defined as the time point when the
infected cells reached 80–90% confluency in selective growth
media.
Cell lysis
Cell pellets were lysed in NP-40 lysis buffer (10 mM Tris-HCl,
pH 7.5; 1% [vol/vol] NP-40; 10% [vol/vol] glycerol; 1 mM
EGTA; 1 mM MgCl2; 150 mM NaCl) supplemented with fresh
5m M b-mercaptoethanol, 10 U/mL RNase Out (Invitrogen),
and complete EDTA-free proteinase inhibitor cocktail tablet
(Roche) on ice for 30 min followed by rocking at 4uC for an
additional 30 min. Cell lysates were centrifuged at 12 100 6g for
30 min at 4uC to remove the insoluble debris. The soluble fraction
was incubated with pre-equilibrated Protein G Sepharose
TM (GE
Healthcare) for 30 min at 4uC with rocking and then centrifuged
at 604 6 g for 3 min at 4uC. Protein concentration in the pre-
cleared soluble fraction was determined using the Bio-Rad Protein
Detection Assay (Bio-Rad).
Immunoprecipitations
FLAG-hTERT was immunoprecipitated from soluble cell lysate
(800–1000 mg) with anti-FLAG M2 affinity resin (Sigma-Aldrich)
in IP buffer 150 (10 mM Tris-HCl, pH 7.5; 1% [vol/vol] NP-40;
10% [vol/vol] glycerol; 1 mM EGTA; 1 mM MgCl2; 150 mM
NaCl) containing 10 U/mL RNase Out (Invitrogen) and EDTA-
free proteinase inhibitor cocktail (Roche) for 2 h at 4uC with
rocking. The protein-bead complexes were washed four times with
either 1 mL of IP buffer 150 (washes 1 and 4) or IP buffer 300 (IP
buffer containing 300 mM NaCl; washes 2 and 3). FLAG-hTERT
was eluted from the affinity resin by two rounds of competitive
elution with excess 36FLAG peptide (Sigma-Aldrich); beads were
resuspended in 30 mL IP 150 buffer containing 2 mg/mL 36
FLAG peptide, rocked for 30 min at 4uC, and then centrifuged at
604 6g for 3 min (4uC).
Western analysis
hTERT protein expression was analyzed in immunoprecipitates
from 293T and BJ cells. SDS-PAGE sample buffer was mixed with
30 mLo f36FLAG peptide eluate and the samples were boiled
for 5 min and resolved by 8% SDS-PAGE. The gel was
transferred to a polyvinylidene diflouride membrane in transfer
buffer (25 mM Tris base; 190 mM glycine; 20% [vol/vol]
methanol; pH adjusted to 8.0), fixed in methanol, air dried, and
blocked with TBS (50 mM Tris-HCl, pH 7.4; 150 mM NaCl)
containing 0.5% Tween-20 and 5% (wt/vol) nonfat dry milk
(NFDM) for 1–2 h at RT. To detect hTERT, blocked membranes
were probed with a 1:1000 dilution of the polyclonal anti-hTERT
antibody [20] (a generous gift from Dr. S. Artandi, Stanford
School of Medicine, Stanford, CA) prepared in TBST (TBS; 0.1%
Tween-20) containing 2.5% (wt/vol) NFDM overnight at 4uC
with gentle rocking. Blots were washed three times for 15–20 min
each in TBST at RT, rinsed in TBS, and incubated with ECL
TM
anti-rabbit immunoglobin G, horseradish peroxidase linked (from
donkey) secondary antibody (GE Healthcare) (1:2000 dilution in
TBST-2.5% [wt/vol] NFDM) for 1 h at RT. The blots were
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once in TBS (5–10 min). Proteins were detected with enhanced
chemiluminescence (ECL) reagent (GE Healthcare), according to
the manufacturer’s instructions.
hTERT-hTR coimmunoprecipitation
hTR was transcribed from an EcoRI-linearized plasmid in the
presence of [a-
32P]UTP (3000 Ci/mmol; 10 mCi/mL; GE
Healthcare) with the MEGAscript T7-coupled expression system
(Ambion, Cedarlane
H Laboratories Ltd.), according to the
manufacturer’s instructions. Unincorporated nucleotides were
removed using G-25 gel filtration microspin columns (GE
Healthcare). Human telomerase was reconstituted using the
RRL TNT
H T7 Transcription-Translation System (Promega,
Fisher Scientific Ltd.) with 30 ng/uL [
32P]UTP-labelled hTR,
60 ng/uL FLAG-hTERT WT, Q169A, Q169D, or Q169N
plasmid DNA, and [
35S]cysteine (.1000 Ci/mmol, 10 mCi/
mL; GE Healthcare). RRL reactions were incubated at 30uC for
60–90 min. hTERT-hTR complexes were immunoprecipitated
using a method similar to that described previously [35].
Limited proteolysis
a-chymotrypsin from bovine pancreas (Sigma-Aldrich) was
reconstituted in 1 mM HCl containing 2 mM CaCl and diluted
to the appropriate working concentration in 16 reaction buffer
(106 stock =200 mM Tris-HCl, pH 8.3; 150 mM MgCl2;
630 mM KCl; 0.5% Tween-20; 10 mM EGTA, pH 8.0). RRL
containing [
35S]cysteine-labelled full length or 1–300 FLAG-
hTERT WT, Q169A, Q169D, or Q169N was digested for 2 min
at 30uCi n1 6reaction buffer containing 10, 100, or 1000 ng/mL
chymotrypsin (Sigma-Aldrich). 15 mL proteolysis reactions con-
tained comparable amounts of [
35S]cysteine-labelled hTERT.
Reactions were terminated by the addition of SDS-PAGE loading
buffer and boiling (5 min). Following digestion, products were
resolved by 12% SDS-PAGE and visualized by autoradiography
and phosphorimaging.
Telomere repeat amplification protocol
Telomerase activity was detected using a modified, two-step
version of the telomeric repeat amplification protocol (TRAP) [36].
In the first step (telomere extension), 1 mL of RRL or 2 mLo f36
FLAG peptide eluate was incubated for 30 min at RT in a 50 mL
volume containing 16reaction buffer (106stock =200 mM Tris-
HCl, pH 8.3; 150 mM MgCl2; 630 mM KCl; 0.5% Tween-20;
10 mM EGTA, pH 8.0), 2.5 mM dATP, dCTP, dGTP, and dTTP,
0.1 mg TS primer (59-AATCCGTCGAGCAGAGTT-39), and 2 U
of Taq DNA polymerase (Invitrogen). In the second step (amplifi-
cation), 0.1 mg of ACX primer (59-GCGCGG[CTTACC]3CTA-
ACC-39)a n d1mLo f[ a-
32P]dGTP (3000 Ci/mmol; 10 mCi/mL;
GE Healthcare) was added to each 50 mL extension reaction, which
was subsequently PCR-amplified for 20–25 cycles consisting of 95uC
for 30 s, 50uC for 30 s, and 72uC for 90 s. TRAP reaction products
(9 mL) were electrophoresed on a nondenaturing 12% (wt/vol)
polyacrylamide gel (29:1 [wt/wt] acrylamide-bisacrylamide) and
detected by autoradiography or exposure to a phosphorimaging
screen.
Conventional telomerase activity assay
The conventional telomerase activity (CTA) assay was used to
measure the activity of human telomerase reconstituted in RRL, as
described previously [28]. The processivity of human telomerase
was determined with pulse-chase conventional telomerase activity
(CTA) assays. In these experiments, RRL containing reconstituted
telomerase was incubated in a 40 mL reaction containing 16CTA
buffer (106stock =500 mM Tris–HCl, pH 8.3; 500 mM KOAc;
10 mM MgCl2;5 0m Mb-mercaptoethanol; 10 mM spermidine),
1.5 mM biotinylated (TTAGGG)3 primer, 1 mM dATP, 1 mM
dTTP, 1.25 mM dGTP, and 6 mL[ a-
32P]dGTP (3000 Ci/mmol,
10 mCi/mL; GE Healthcare) at 30uC for 5 min (pulse). The pulse
reaction was chased with 200 mM non-biotinylated (TTAGGG)3
primer for 5, 15, or 30 min (chase) and terminated by incubating
with stop buffer (10 mM EDTA; 2 M NaCl; 0.1 mg/mL RNase
A) at 37uC for 15 min. Elongated biotinylated pulse primers were
separated from elongated non-biotinylated chase primers using the
method described previously [28].
Telomerase activity was measured using data collected with the
standard CTA assay and processivity was calculated with the data
obtained in pulse-chase CTA experiments. Using phosphoimager
analysis and Quantity One
H version 4.5.0 software (Bio-Rad), the
signal of each elongation product was quantified and normalized
to the total number of labeled dGTP incorporated. Telomerase
activity within one hexameric repeat (Pi) was calculated using the
formula Pi =( T i + Ti+1 + … + Ti+5). T values correspond to the
signal of the elongation product at position i. The normalized
values obtained at positions Ti …T i+5 in each independent
experiment were added and expressed as a fraction of WT
telomerase activity. The mean activity was determined from three
independent experiments and the results are reported6SEM.
GraphPad InStat version 3.00
H (GraphPad Software) was used to
calculate Student’s two-tailed unpaired T-tests and determine if
total DNA synthesis was statistically different for human
telomerase reconstituted with hTERT WT versus Q169A,
Q169D, or Q169N.
Repeat addition processivity (Pi) was calculated using methods
similar to those described previously [37,38]. The normalized
signals of the +6, +12, +18, +24, +30, and +36 elongation products
were applied to the formula Pi =( T i+6)/(Ti + Ti+6). First, repeat
addition processivity was calculated for each pair of elongation
products. Next, the repeat addition processivity values at each
position were summed to determine the overall processivity. The
overall processivity results of three independent experiments were
averaged and the SEM was calculated. Average repeat addition
processivity for mutant telomerases was then expressed relative to
the wild type enzyme and the SEM was calculated. Statistical
significance was assessed using GraphPad InStat version 3.00
H
(GraphPad Software).
Primer binding assay
hTERT was synthesized in the absence of hTR with the RRL
TNT
H T7 Transcription-Translation System (Promega, Fisher
Scientific Ltd.), as described in [28]. [
35S]cysteine-labelled hTERT
proteins were tested for the ability to interact with 59-biotinylated
oligonucleotides using a slightly modified version of the previously
described DNA-binding assay [28], in which the primer mix was
incubated on ice for 45–60 min prior to adding [
35S]cysteine-
labelled hTERT. Primer binding results were analyzed as
described [28], with the exception that reaction products were
quantified by phosphoimager analysis.
Telomere restriction fragment analysis
Telomeres were visualized by in-gel hybridization of HinfI and
RsaI restriction enzyme-digested genomic DNA (5 mg) with a
telomeric DNA probe (generously provided by Dr. J. Karlseder,
Salk Institute for Biological Studies, La Jolla, CA), (TTAGGG)x,
labelled with Klenow and [a-
32P]dGTP (3000 Ci/mmol, 10 mCi/
mL; GE Healthcare). Aliquots of digested DNA were electropho-
resed through a 0.6% agarose gel at 500 Vh. Gels were denatured
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neutralized for 45 min in neutralization solution (1 M Tris, pH 8.0;
1.5 M NaCl), and dried at RT (45 min) and 60uC( 4 5m i n ) .T h e
dried gel was subsequently denatured for 10 min and neutralized for
10 min before hybridization in 56 SSC (206 stock =3 M NaCl;
300 mM sodium citrate) containing
32P-labelled telomeric probe at
37uC for 20 h. Hybridized gels were washed three times in 26SSC
for 10 min (RT), washed once in nuclease-free water for 5 min (RT),
dried for 20 min at 60uC, and exposed to a phosphoimager screen
overnight. Mean telomere length was calculated from at least three
independent experiments using OptiQuant
TM version 5.0 software
(PerkinElmer, Inc.).
b-galactosidase staining
Adherent BJ cells grown in 10 cm culture dishes were washed in
PBS (pH 7.2), fixed for 3–5 min at RT in PBS (pH 7.2) containing
0.5% gluteraldehyde (Sigma-Aldrich), washed with PBS (pH 7.2)
supplemented with 1 mM MgCl2, and stained overnight at 37uC
(no CO2) with fresh b-galactosidase staining solution: PBS
(pH 6.0) containing 1 mg/mL 5-bromo-4-chloro-3-indolyl b-D-
galactoside (X-Gal) (stock =20 mg/mL in dimethylformamide),
1 mM MgCl2, 120 mM potassium ferricyanide, and 120 mM
potassium ferrocyanide. Staining was evident the next day; stained
cells were washed in PBS (pH 7.2) and visualized with bright-field
microscopy.
Results
Q169 mediates the polymerase function of human
telomerase in vitro
We first determined whether the evolutionarily-conserved Gln
residue in the TEN domain was required for human telomerase
activity in vitro using the telomere repeat amplification protocol
(TRAP). We found that human telomerase reconstituted with
hTERT Q169A, Q169D, or Q169N exhibited a dramatic
reduction in catalytic activity compared to the WT enzyme
(Figure 2A). Control reactions showed that RNase A inhibited
these reactions, indicating that DNA synthesis was catalyzed by
telomerase and not by contaminating polymerases present in
RRL. The Q169D substitution was particularly disruptive and
largely eliminated enzymatic activity, perhaps due to electrostatic
repulsion between the polyanionic DNA backbone and electro-
negative carboxylic acid side-chain.
The TRAP is a highly sensitive method to detect telomerase
activity. However, it does not distinguish between enzymes with
catalytic defects (i.e. impaired DNA polymerization) and non-
processive enzymes with translocation defects that synthesize less
than four telomeric repeats [36,39]. Therefore, we used the
conventional telomerase activity assay (CTA) to gain more insight
into the catalytic defects of the hTERT Q169 mutants. Similar to
the TRAP results, human telomerase reconstituted with hTERT
Q169A, Q169D, or Q169N exhibited markedly reduced activity
compared to the WT enzyme when tested with an 18 nt telomeric
ssDNA primer, bio-TELO18 (Figure 2B and Table 1). CTA assays
were performed with bio-TELO18 because human telomerase
exhibits robust activity with this primer [28], although we
observed similar catalytic defects with a shorter primer, bio-
TELO6 (data not shown). Quantification of three independent
experiments showed that telomerase reconstituted with hTERT
Q169A was approximately 20% as active as the WT enzyme
(p,0.001) (Figure 2B). The activity defect was more severe for
telomerases reconstituted with either hTERT Q169D or hTERT
Q169N, which were only 11% and 14% as active as WT
telomerase, respectively (p,0.001). We observed a striking defect
in the ability of the Q169 mutants to incorporate the second
nucleotide, which corresponds to the second G in the extension
product 59-GGGTTAG-39. This could be explained if the Q169
mutants have reduced affinity for the nucleotide that would be
incorporated at this position. However, we have been unable to
Figure 2. In vitro telomerase activity of hTERT Q169 mutants. A,
Human telomerase was reconstituted in rabbit reticulocyte lysates (RRL)
with hTR and FLAG-hTERT WT, Q169A, Q169D, or Q169N and tested for
in vitro enzyme activity using the telomere repeat amplification
protocol. RRL reconstitution reactions (1 mL) were assayed in the
presence and absence of 5 mg RNAse A. The triangles represent a five-
fold dilution of each reaction to confirm that the amplification assays
were in the linear range. B, Human telomerase reconstituted in RRL with
hTR and FLAG-hTERT WT, Q169A, Q169D, or Q169N was tested for
activity using the conventional telomerase activity assay and an 18 nt
canonical human telomeric primer, bio-TELO18. Mean telomerase
activity within the first hexameric repeat was calculated from three
independent experiments and reported relative to the WT enzyme.
Mean values6SEM are shown at bottom of each lane. The asterisk
indicates 22 nt elongation products, as determined by comparison with
the mobility of a 59-end-radiolabelled 18 nt telomeric primer containing
39-biotin (not shown).
doi:10.1371/journal.pone.0007176.g002
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affinity constants cannot be performed with RRL-reconstituted
human telomerase. This is due to the high abundance of
endogenous RRL proteins and the inability to accurately quantify
the concentration of functionally-competent telomerase. Similar
arguments exist for FLAG-immunoprecipitated human telome-
rase. An alternative, but not necessarily independent explanation is
that substitution of Q169 altered hTERT conformation, which
prevented efficient nucleotide incorporation (below).
Pulse-chase CTA experiments indicated that mutation of
hTERT Q169 did not affect repeat addition processivity
(Figure 3). A direct correlation was observed between the length
of the extended pulse primer and the time that WT and Q169A
telomerase was incubated with chase DNA, indicating that
telomerase remained associated with bio-TELO18 and catalyzed
processive DNA synthesis. Quantification of the repeat addition
processivity within the first five telomeric repeats revealed that
hTERT Q169A was at least 95% as processive as WT telomerase
when pulsed with bio-TELO18 and chased with TELO18
(p.0.05). This data suggests that hTERT Q169 has a critical
role in the first round of DNA synthesis but is less important for
subsequent rounds of DNA synthesis (i.e. translocation). However,
we cannot rule out a potential role for Q169 in repeat addition
processivity since were unable to quantify the processivity of
telomerase reconstituted with hTERT Q169D or Q169N.
Biochemical characterization of hTERT Q169
T oi n v e s t i g a t et h eb a s i sf o rt h ea c t i v i t yd e f e c t s ,w ed e t e r m i n e d
whether Q169 modulates hTERT stability, conformation, and
physical interactions with hTR. There was no appreciable difference
in the protein levels of [
35S]cysteine-labelled hTERT WT, Q169A,
Q169D, or Q169N (Figure 4A), indicating that Q169 mutagenesis
does not have a significant impact on hTERT stability in vitro.
However, it remained possible that Q169 mutation might induce a
Figure 3. Repeat addition processivity of hTERT Q169 mutants. Pulse-chase conventional telomerase activity assays were used to measure
the repeat addition processivity of telomerase with bio-TELO18. The telomerase reaction was initiated with 1.5 mM bio-TELO18. Telomerase was
allowed to extend bio-TELO18 for 5 min and then challenged with 200 mM chase primer (TELO18) for 5, 15, and 30 min. The first three lanes in each
panel represent control reactions (left to right): pulse (5 min), reactions performed with pulse primers alone to show that telomerase can efficiently
elongate this primer; pulse + chase, pulse and chase primers added simultaneously to demonstrate the efficiency of the chase conditions; chase
(30 min), reactions performed with the chase primer alone to show that the non-biotinylated reaction products were not isolated on streptavidin
beads. Repeat addition processivity within the first five repeats was calculated from three independent experiments. Mean values are reported6SEM
at the bottom of each lane. Asterisks denote the position of the 22 nt elongation product, as determined by comparison with the mobility of a
59-end-radiolabelled 18 nt telomeric oligonucleotide harboring a 39-biotin residue (not shown). nd, not determined.
doi:10.1371/journal.pone.0007176.g003
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without compromising protein stability. Therefore, RRL containing
comparable levels of [
35S]cysteine-labelled WT or Q169 mutated
hTERT wassubjected to limited proteolysis usingchymotrypsin.The
hTERT Q169A, Q169D, and Q169N mutants were found to be
more sensitive to chymotrypsin digestion than WT hTERT
(Figure 4B). Specifically, the signal intensity of [
35S]cysteine-labelled
proteolytic fragments migrating at approximately 20 kDa was
diminished in hTERT Q169A, Q169D, and Q169N. This was an
hTR-independent effect because the proteolytic fragments derived
from hTERT reconstituted in the presence of hTR were indistin-
guishable from those observed in its absence (Figure S1). This
observation was confirmed with time-course proteolytic digestions of
[
35S]cysteine-labelled hTERT WT, Q169A, Q169D, or Q169N that
were synthesized in the presence and absence of hTR (Figure S2).
To gain insight into the identity of the proteolytic fragments at
approximately 20 kDa, we performed limited proteolysis on
truncated hTERT proteins containing the first 300 amino acids. A
comparison of the proteolytic profiles of [
35S]cysteine-labelled 1–
300 hTERT WT and Q169A, Q169D, and Q169N revealed a
reduction in the 20 kDa proteolytic fragment in the Q169
mutants, similar to the results obtained with full length hTERT
(Figure S3). This provides the first experimental evidence that
Q169 is important for the structure of the hTERT N-terminus.
Interactions between hTERT and hTR are essential for
telomerase activity and some mutations in hTERT that impair
hTR-binding reconstitute nonfunctional enzymes [34,35,40].
Thus, defects in hTERT-hTR assembly could potentially explain
the loss of activity observed with the hTERT Q169 mutants. To
test this possibility, human telomerase was reconstituted with
Figure 4. Biochemical analysis of hTERT Q169 mutants. A, Mutation of hTERT Q169 does not compromise protein stability. SDS-PAGE and
autoradiography was used to assess protein expression and stability in RRL (left to right): pCI vector alone, FLAG-hTERT WT, FLAG-hTERT Q169A, FLAG
hTERT Q169D, and FLAG-hTERT Q169N. RRL reactions (2 mL) were resolved by 8% SDS-PAGE and visualized by autoradiography and
phosphorimaging. B, hTERT Q169 mediates hTERT conformation. Comparable amounts of [
35S]cysteine-labelled FLAG-hTERT WT, Q169A, Q169D,
or Q169N was incubated with 0, 10, 100, or 1000 ng/mL chymotrypsin at 30uC for 2 min and resolved by 12% SDS-PAGE. Arrows indicate the
proteolytic fragments that are diminished upon substitution of hTERT Q169. C, Substitution of hTERT Q169 does not abrogate hTERT-hTR interactions.
[a-
32P]UTP-labelled hTR (indicated by asterisks) was coimmunoprecipiated with [
35S]cysteine-labelled FLAG-hTERT WT, Q169A, Q169D, and Q169N
(indicated by arrow). Coimmunoprecipitates were resolved by 4–15% SDS-PAGE and visualized by autoradiography and phosphorimaging.
doi:10.1371/journal.pone.0007176.g004
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32P]UTP-labelled hTR and [
35S]cysteine-labelled-FLAG-
hTERT WT, Q169A, Q169D, or Q169N. [
35S]cysteine-labelled
hTERT was immunoprecipitated with FLAG antibodies and
analyzed for [a-
32P]UTP-labelled hTR. As shown in Figure 4C,
the hTERT Q169 mutants bound hTR as efficiently as hTERT
WT, indicating that the functional defects observed with these
mutants were not due to abrogated hTERT-hTR interactions.
hTERT Q169 mutants retain sequence-specific ssDNA-
binding activity
Telomeric primers have to be positioned correctly within the
telomerase active site to initiate reverse transcription. In addition to
primer-template interactions, this requires interactions between the
TERT RT domain and DNA 39-end, as well as between the N-
terminus (anchor region) and DNA 59-end [11]. Thus, suboptimal
interactions between hTERT and DNA primers could explain the
activity defects observed with hTERT Q169 mutants. We used a
recently-developed DNA-binding assay to characterize physical
interactions between hTERT WT, Q169A, Q169D, and Q169N
and59-biotinylatedssDNAprimers(Table1)[28].Wefoundthatthe
Q169 mutants retained sequence-specific DNA-binding activity in
vitro (Figures 5A and B). When compared with hTERT WT,
however, the Q169 mutants exhibited subtle differences in their
interactions with specific lengths of human telomeric DNA
(Figure 5A). The relative strength of the interaction between short
telomeric primers (bio-TELO12 and bio-TELO6) and each of the
Q169 mutants was greater than that observed for hTERT WT. This
was also observed between hTERT Q169A and bio-TELO24, and
may reflect tighter binding of the primers to the Q169 mutants. In
contrast, the relative strength of the interaction between hTERT
Q169D or Q169N and bio-TELO30, the longest primer we tested,
was significantly reduced.
We next tested the Q169 mutants for interactions with non-
human telomeric or random ssDNA to determine whether Q169
was important for hTERT’s sequence-specificity. As shown in
Figure 5B, hTERT Q169A, Q169D, and Q169N demonstrated
sequence-specific DNA-binding that was indistinguishable from
hTERT WT. The interactions between Q169 mutants and
primers containing either 18 nt (bio-antiTELO18) or 24 nt (bio-
pBR and bio-BBP) of non-telomeric DNA were not statistically
different from those observed with hTERT WT (p.0.05). When
tested with primers representing the telomeres of other organisms,
hTERT WT and Q169 mutants interacted very efficiently with a
primer containing 18 nt of Tetrahymena telomeric DNA (bio-
Tetrahymena) and much less efficiently with a primer containing
15 nt of S. cerevisiae telomeric DNA (bio-Yeast) (Figure 5B). The
interaction with bio-Tetrahymena is consistent with the ability of
WT human telomerase to elongate primers containing this G-rich
sequence (TTGGGG) [22].
Q169 mediates the ability of truncated hTERT proteins to
interact with ssDNA
TERT contains multiple DNA-binding regions that make it
difficult to assess how one amino acid influences DNA-binding
[29]. We therefore introduced the Q169 mutations into the
isolated hTERT TEN domain (amino acids 1–196) and the tested
these mutants for DNA-binding. However, we were unable to
detect stable interactions between the TEN domain and telomeric
ssDNA primers (data not shown). Therefore, the Q169A, Q169D,
and Q169N mutations were cloned into an hTERT fragment
comprised of residues 1 to 300 [28]. Each of the hTERT 1–300
constructs exhibited readily apparent ssDNA-binding activity
(Figure 6A). However, the Q169 substitutions caused a reduction
in the relative strength of the interactions between hTERT 1–300
and short telomeric primers (bio-TELO12 and bio-TELO6). This
result provided an interesting contrast to that observed with full
length proteins, where mutation of Q169 increased the apparent
strength of the interaction with bio-TELO12 and bio-TELO6
(Figure 5A). Furthermore, the 1–300 hTERT Q169 mutants
showed a marked decrease in the interaction with primers
comprised of yeast telomere (bio-Yeast) or random (bio-pBR and
bio-BBP) DNA (Figure 6B). Taken together, the data presented in
Figures 6A and B indicate that Q169 is involved in the ssDNA-
binding activity of the hTERT N-terminus and thus, contributes
to anchor site interactions in human telomerase.
Q169 mediates the cellular functions of human
telomerase
To extend our in vitro studies, we determined if Q169 mediates
the biological activity of telomerase in human cells. hTERT
Q169A was stably expressed in telomerase positive (SV40 large T-
antigen transformed embryonic kidney cells; 293T) and telomerase
negative (foreskin fibroblasts; BJ) human cells. Q169A was chosen
as a representative mutant for these experiments since this
substitution was the least detrimental to telomerase activity in vitro.
We first investigated the cellular function of hTERT Q169A in
293T cells. Figure 7A shows that anti-FLAG-immunoprecipitated
hTERT WT exhibited robust TRAP activity whereas the Q169A
mutant was consistently inactive. The loss of telomerase activity
was not due to abrogated protein expression (Figure 7A) or nuclear
exclusion (data not shown). As expected, telomere elongation was
observed in 293T cells expressing hTERT WT but not in those
expressing the catalytically inactive Q169A mutant (Figure 7B). As
mentioned above, 293T cells contain functional endogenous
telomerase. This allowed us to investigate whether hTERT
Q169A inhibited the action of endogenous telomerase at
telomeres. Bulk telomere length in cells stably expressing hTERT
Q169A was similar to that of vector-only control cells (Figure 7B),
although the vector-only cells have slightly longer telomeres upon
infection. In both of these cell lines, telomeres do not shorten with
increased passage number. Furthermore, neither the vector only
cells nor the cells expressing Q169A underwent apoptosis and can
be maintained in culture (data not shown), unlike other dominant
negative alleles of hTERT [41,42]. Collectively, these data
indicate that hTERT Q169A does not function as a dominant
negative protein in 293T cells.
The cellular function of hTERT Q169A was also investigated in
normal diploid fibroblasts (BJ cells). Telomerase negative BJ cells
provide a strong cellular contrast to the telomerase positive 293T
cells and thus, control for cell line-dependent phenotypes.
Expression of hTERT WT, but not Q169A, conferred BJ cells
with telomerase activity (Figure 8A). The lack of telomerase
activity in immunoprecipitates containing hTERT Q169A was not
due to abrogated protein expression (Figure 8A). Furthermore,
stable expression of hTERT WT induced telomere elongation
during early passages and telomere length maintenance during
later passages (Figure 8B). These cultures completed approxi-
mately three times more mean population doublings (mpd) than
the vector-only control cells, and did not exhibit senescence-
associated b-galactosidase activity (Figures 8C and D, respectively)
[43]. The BJ cells expressing hTERT Q169A exhibited defects in
telomere length maintenance, exhausted their replicative potential
after 25 mpd, and did not surmount replicative senescence
(Figures 8B–D). Although the BJ cells expressing hTERT Q169
appear shorter at mpd 22 than the vector only control cells, the
bulk telomere length of the control cells were slightly longer upon
infection than in the hTERT Q169A cells due to the fact that
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shortening in these cells are similar. Thus, mutation of hTERT
Q169 inhibited human telomerase function in living cells.
Discussion
hTERT Q169 is essential for human telomerase activity
Important questions in telomerase biochemistry pertain to the
mechanisms by which the enzyme recognizes and orientates
telomeric ssDNA in the active site and catalyzes processive
telomere synthesis. A long-standing notion is that telomerase has
two modes of primer recognition: initial recognition of a telomere
sequence and/or structure at the DNA 59-end and subsequent
identification of the 39-terminus to prime the addition of telomeric
nt [11]. Template-independent enzyme-DNA interactions are
known as anchor site interactions and a subset of these are
believed to confer telomerase with the property of repeat addition
processivity. After synthesizing a complete telomeric repeat,
Figure 5. hTERT Q169 mutants interact sequence-specifically with telomeric ssDNA. The primer binding assay was used to investigate
interactions between hTERT WT and Q169 mutants and 59-biotinylated ssDNA primers comprised of A, different lengths of human telomeric DNA and
B, non-human telomeric or random DNA. Primer sequences are listed in Table 1. hTERT-DNA complexes were immobilized on neutravidin beads and
separated by 8% SDS-PAGE and visualized with autoradiography and phosphorimaging (left panels). Quantification and statistical analysis of at least
three independent experiments is shown in the graphs (right panels). Mean values are reported6SEM. Asterisks denote levels of statistical
significance compared to the interaction between hTERT WT and the corresponding primer; p,0.05 (*) and p,0.01 (**).
doi:10.1371/journal.pone.0007176.g005
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template are melted so that the nascent DNA 39-end can be
repositioned with the template for the next round of telomere
synthesis. During this dynamic process, the telomerase anchor
site(s) remains associated with upstream nt and prevents the
enzyme from dissociating off the DNA primer.
The crystal structure of the Tetrahymena TEN domain revealed a
ssDNA-binding groove on the surface that contained several
phylogenetically-conserved residues, including the Gln residue
investigated here [30,33]. Alanine mutagenesis of tTERT Q168
significantly impaired telomerase activity without affecting repeat
addition processivity and identified a role for this residue in ciliate
telomerase anchor site interactions [30,33]. The corresponding
mutation in Est2p severely decreased yeast telomerase activity in
vivo [31]. Here, we show for the first time that human telomerase
reconstituted with hTERT Q169A, Q169D, or Q169N exhibits
severe defects in DNA polymerization in vitro and in vivo, indicating
that the invariant Gln residue has an evolutionarily-conserved role
Figure 6. Q169 mediates physical interactions between truncated hTERT proteins and ssDNA. The primer binding assay was used to test
the ability of truncated hTERT proteins comprised of amino acids 1–300 (WT and Q169 mutants) to bind 59-biotinylated ssDNA primers comprised of
A, different lengths of human telomeric DNA and B, non-human telomeric or random DNA (Table 1). hTERT-DNA complexes were immobilized on
neutravidin beads and separated by 8% SDS-PAGE and visualized with autoradiography and phosphorimaging (left panels). Quantification and
statistical analysis of at least three independent experiments is in graphical format (right panels) and the mean is reported6SEM. Asterisks denote
levels of statistical significance compared to hTERT 1–300 WT binding to the corresponding DNA primer; p,0.05 (*), p,0.01 (**), and p,0.001 (***).
doi:10.1371/journal.pone.0007176.g006
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role of this residue by revealing its importance for the ability of
telomerase to incorporate nucleotides at the second position of the
RNA template. Importantly, the loss of telomerase activity in vivo
was not due to nuclear exclusion or abrogated protein expression,
although protein levels were reduced compared to hTERT WT.
Interestingly, yeast strains expressing endogenous Est2p Q146A
suffered severe growth defects and telomere attrition, and
exhibited a reduction in Est2p protein levels [31,44]. Thus, it
appears that living cells do not tolerate high expression levels of
TERT proteins harboring mutations of the invariant Gln residue.
In the absence of crystallographic data of hTERT, we can only
speculate on the mechanism underlying the severity of the Q169D
and Q169N mutations in relation to Q169A. As mentioned
previously, the non-conservative Q169D substitution could cause
electrostatic repulsion between the polyanionic DNA backbone
and electronegative carboxylic acid side-chain. Our observation
that the conservative Q169N does not rescue the catalytic
phenotype indicates that both the length and the hydrogen-
bonding potential of the side chain at position 169 are critical for
the activity of human telomerase. The finding that hTERT
Q169A reconstitutes weak telomerase activity is likely due to the
fact that this is a neutral amino acid substitution. Although both
Ala and Asn potentially eliminate important hydrogen-bonding
interactions that would be normally fulfilled by Gln, the Q169N
substitution is more detrimental to activity. One interpretation of
this data is that the Asn substitution also introduces an unfavorable
interaction whereby the shorter side chain prevents the amide
group from satisfying its hydrogen-bonding potential.
Finally, we note that this residue appears to have evolved some
species-specific functions. Alanine substitution of the correspond-
ing residue in Est2p significantly impaired repeat addition
processivity in vitro [31]. One intriguing explanation for these
differences might be that telomerase uses different mechanisms to
interact with different sequences of telomeric DNA. It is
conceivable that ciliate and human telomerase use similar
mechanisms to bind and synthesize telomeric DNA because of
the high degree of telomere sequence similarity (TTGGGG and
TTAGGG, respectively). In contrast, yeast telomeres are degen-
erate (e.g. G2–3(TG)1–6 in S. cerevisiae) [45] and different molecular
mechanisms might be used for telomere length maintenance in this
organism.
Q169 alters the sensitivity of the hTERT N-terminus to
proteolytic digestion
Telomerase is thought to contain template-distal and template-
proximal anchor sites [11]. It has been speculated that a
conformational change in the template-proximal anchor site is
required for telomerase to transition into an elongation-competent
complex [11]. Structure-function studies with Tetrahymena telome-
rase suggested that the ssDNA-binding groove on the surface of
the TEN domain formed part of a template-proximal anchor site
[30,33]. Photo-cross-linking studies with tTERT and short
telomeric ssDNA suggested that the TEN domain was displaced
Figure 7. hTERT Q169 is required for telomerase activity and telomere length-maintenance in transformed human cells. A, Extracts of
293T cells stably expressing pBABEpuro, pBABEpuro-FLAG-hTERT WT, or pBABEpuro-FLAG-hTERT Q169A were immunoprecipitated with anti-FLAG
antibodies. FLAG-hTERT was eluted from the beads by competition with excess 36FLAG peptide. 2 mL of eluate was tested for telomerase activity by
the telomere repeat amplification protocol (top panel) and 35 mL was resolved by 8% SDS-PAGE and examined for hTERT expression by Western
blotting with anti-hTERT antibodies (bottom panel). The mean population doubling is indicated above each lane. na, not applicable. B, Bulk telomere
length was measured using the terminal restriction fragment analysis. Mean telomere length and standard error of the mean (SEM) was calculated
from at least three independent experiments and is indicated below each lane. The mean population doubling is indicated above each lane. Arrows
are included for visual clarification and represent the approximate mean of each sample.
doi:10.1371/journal.pone.0007176.g007
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proposed that this movement was needed to reposition the
template-proximal anchor site relative to the active site and
correctly orientate the DNA primer or DNA-RNA heteroduplex
in the active site during primer elongation [30,33].
In this work, we investigated the structural significance of
hTERT Q169 directly by using limited proteolysis to monitor the
conformational flexibility of mutant proteins. Importantly, our
results indicated that the overall conformation of hTERT Q169A,
Q169D, and Q169N was intact. However, the NTE of the Q169
mutants was more sensitive to chymotrypsin proteolysis than
hTERTWT.Thisis interpreted asevidencethat Q169 is important
for the conformation of the hTERT N-terminus. We believe that
that a small fraction of the mutant proteins attained WT
conformation because there was not a complete loss of the 20
kDa fragments. It is possible that these Q169 mutants are
catalytically competent and thus, are responsible for the low levels
ofprocessivetelomerase activityweobserve invitro(discussedbelow).
hTERT Q169 mutants physically interact with hTR
TERT contains an essential and universally-conserved telome-
rase RNA-binding domain (TRBD) that makes extensive contacts
Figure 8. hTERT Q169 is required for telomerase activity, telomere length-maintenance, and hTERT-mediated immortalization in
primary human cell lines. A, Extracts from BJ cells stably expressing pBABEpuro, pBABEpuro-FLAG-hTERT WT, or pBABEpuro-FLAG-hTERT Q169A were
immunoprecipitated with anti-FLAG antibodies. FLAG-hTERT was eluted from the beads by competition with excess 36FLAG peptide. 2 mL of eluate
was tested for telomerase activity by the telomere repeat amplification protocol (top panel) and 35 mL was resolved by 8% SDS-PAGE and examined
for hTERT expression by Western blotting with anti-hTERT antibodies (bottom panel). The mean population doubling is indicated above each lane. B,
Bulk telomere length was measured using the terminal restriction fragment analysis. Mean telomere length and standard error of the mean (SEM) was
calculated from at least three independent experiments and is indicated below each lane. The mean population doubling of each culture is indicated
above the lane. Arrows are included for visual clarification and represent the approximate mean of each sample. C, Biological activity of hTERT Q169A
was investigated by continuously passaging BJ cells to determine if the cultures entered replicative senescence or bypassed this proliferative
blockade, as determined using growth curves. D, b-galactosidase activity at pH 6.0, a well-known marker of replicative senescence, was monitored
using conventional staining techniques to detect blue-colored cells. Representative BJ cells stably expressing the empty vector or FLAG-hTERT Q169A
exhibited blue staining that coincided with the cessation of proliferation. In contrast, cells stably expressing FLAG-hTERT stained negative for
b-galactosidase activity (pH 6.0). The mean population doubling of each culture is indicated in parenthesis.
doi:10.1371/journal.pone.0007176.g008
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seemed unlikely that substitution of hTERT Q169 would disrupt
hTERT-hTR interactions since this residue is not located in the
TRBD. We confirmed here that hTERT Q169 is not involved in
critical hTERT-hTR interactions. However, we cannot rule out
the possibility that Q169 substitution causes small changes in
hTR-binding that are masked in the context of the full length
protein. Similarly, Q169 could regulate conformational changes in
hTR or the RNP complex that are required for telomerase
activity.
Q169 mediates ssDNA-binding activity in hTERT
In this work we show that hTERT proteins containing Q169A,
Q169D, or Q169N mutations retained telomere sequence-specific
ssDNA-binding activity in vitro. However, when compared to
hTERT WT, the Q169 mutants exhibited subtle differences in the
relative strength of the interactions with telomeric ssDNA. In
parallel, we investigated the DNA-binding properties of hTERT
1–300 variants containing the Q169 substitutions. hTERT 1–300
Q169A, Q169D, and Q169N also retained telomeric ssDNA-
binding activity and demonstrated subtle differences in the relative
strength of protein-DNA interactions when compared to 1–300
WT. While the presence of multiple DNA-binding sites in TERT
complicates the interpretation of this data [28,29], these studies
clearly indicate that Q169 is involved in protein-telomeric DNA
interactions, thereby identifying a novel residue in hTERT that
regulates ssDNA-binding activity (discussed below). Future studies
are required to determine Q169 has a direct or indirect effect on
DNA-binding.
Interestingly, the hTERT Q169 mutations cause an increase in
the relative strength of the interaction between the full length
protein and short telomeric ssDNA primers whereas they decrease
the interactions between hTERT 1–300 and these primers. We
have previously identified multiple DNA-binding regions through-
out the hTERT protein, including the N-terminus, RT domain,
and C-terminus [28]. Similar results have now been reported for
ciliate TERT [29]. Importantly, the DNA-binding regions appear
to co-operate during telomeric ssDNA-binding in vitro and establish
a dynamic ‘DNA-binding equilibrium’ in which the primer can
interact with any or all of the DNA-binding domains [28,29]. The
data presented in Figures 5 and 6 suggests that the Q169
mutations have disrupted an important DNA-binding domain in
the hTERT N-terminus thereby favoring an interaction with the
remaining DNA-binding domains. Our observation that short
ssDNA primers interact with the full length Q169 mutants to a
greater extent than wild type hTERT implies that in the context of
full length hTERT, Q169 negatively regulates the overall strength
of the interaction with short telomeric primers. The apparent
decrease in the strength of the interaction between bio-TELO30
and hTERT Q169D and Q169N, however, implies that Q169
may also be required to stabilize interactions with longer stretches
of telomeric ssDNA. In contrast to full length hTERT, mutation of
Q169 decreases the interaction between short telomeric primers
and hTERT 1–300. One logical explanation for this decrease is
that the 1–300 mutant lacks many of the previously identified
DNA-binding regions in hTERT. Thus, Q169 has an important
role in stabilizing the interactions that occur between the hTERT
N-terminus and short telomeric ssDNA primers in vitro. Impor-
tantly, we have previously shown that the hTERT 1–300 fragment
has a strong non-sequence-specific ssDNA-binding activity in vitro
[28]. We interpreted this to mean that the hTERT N-terminus
contains a strong ssDNA-binding activity but regions beyond the
N-terminus are important for TTAGGG-specific ssDNA-binding.
We show here that substitution of Q169 in the context of hTERT
1–300 causes a significant decrease in the ability of this fragment
to bind ssDNA primers comprised of random or yeast telomeric
ssDNA (Figure 6B). This observation identifies a previously
unrecognized role for hTERT Q169 in regulating sequence-
specific interactions between the protein’s N-terminus and ssDNA
primers in vitro. Our data supports previous studies that identified a
potential role for Q168 in mediating ciliate telomerase’s affinity for
telomeric ssDNA [30,33]. Collectively, these studies indicate that
the Gln residue has an evolutionarily-conserved role in regulating
TERT-telomeric ssDNA interactions (i.e. anchor site interactions).
Conceptual model to describe the catalytic phenotype of
hTERT Q169 mutants
Recently, Zaug et al. proposed a model for telomerase activity in
which the catalytic cycle is regulated by a series of conformational
changes [32]. It was suggested that telomerase initiates DNA
synthesis when the TEN domain is in close proximity to the
remainder of the RNP (‘closed state’). This conformation is
regulated by an intramolecular protein-protein interaction be-
tween the TEN domain and an as yet unidentified residue [32].
Once the first round of telomere synthesis is complete, this
interaction is broken and the TEN domain is displaced relative to
the catalytic site, which relaxes the RNP into an ‘open state’.
Displacement of the TEN domain repositions the template-
proximal anchor site and template region, and restores base-
pairing between the DNA 39-end and template 59-end. It is
thought that the DNA 59-end slides through the ssDNA-binding
groove on the TEN domain, which signals the RNP to return to
the closed state for the next round of telomere synthesis. This
model invokes conformation changes within telomerase that are
similar to those described for bacterial and eukaryotic RNA
polymerases during the transition from transcription initiation to
elongation (reviewed in [48,49]). For example, the initial loading
of promoter DNA onto RNA polymerase II triggers a series of
structural changes that include the closure of an evolutionarily-
conserved ‘clamp’ over the template and transcript. Clamp closure
converts the enzyme from an open to a closed state that is required
for transcription elongation. It is intriguing to speculate that the
TEN domain could be involved in processes that are similar to the
RNA polymerase clamp structure.
We interpret the increased protease-sensitivity of full length and
1–300 hTERT Q169 mutants as evidence that the N-terminus
adopts a conformation that is more accessible to chymotrypsin
than WT hTERT (i.e. greater conformational flexibility). We
speculate that the mutants cannot easily convert between open and
closed states (above), which alters critical telomerase-DNA
interactions and causes severe catalytic defects. This seems
particularly important for the ability of human telomerase to
incorporate nucleotides at the second position of the hTR
template. We suggest that the minimal activity observed with
Q169 mutants in vitro stems from a small population of enzymes
that correctly orientate the DNA primer and/or DNA-RNA
hybrid in the active site to catalyze telomere synthesis. This is
consistent with the fact that we do not observe a complete loss of
the 20 kDa proteolytic fragment in our limited proteolysis
experiments. According to the model proposed by Zaug et al.,
Q169 is not directly involved in repeat addition processivity [32],
which is consistent with our observation that hTERT Q169A
demonstrates normal repeat addition processivity. We propose
that the mechanism by which Q169 regulates telomerase activity
involves conformational changes that promote optimal enzyme-
primer-substrate interactions and facilitate the efficient incorpo-
ration of nucleotides during the first round of telomere synthesis.
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In summary, we show that Q169 is a functionally critical residue
in human telomerase and provide the first detailed evidence
regarding the biochemical and cellular significance of this
evolutionarily-conserved Gln residue in higher eukaryotes. The
intimate relationship between telomerase and human disease
underscores the importance for structure-function studies that
elucidate regions in hTERT that could be amenable to therapeutic
intervention. Our studies are necessary, but not sufficient, for a
complete understanding of how the TEN domain contributes to
telomerase structure, activity, and telomere length maintenance in
higher eukaryotes. Importantly, since Q169 is essential for
telomerase activity in vivo, this residue could represent a novel
target for therapeutic intervention of telomerase activity in human
diseases like cancer.
Supporting Information
Figure S1 Q169 mediates hTERT conformation independently
of hTR. RRL containing in vitro transcribed hTR and
[35S]cysteine-labelled FLAG-hTERT WT, Q169A, Q169D, or
Q169N was incubated with 0, 10, 100, or 1000 ng/mL
chymotrypsin at 30uC for 2 min. 15 mL proteolysis reactions
contained comparable amounts of [35S]cysteine-labelled hTERT.
Reactions were terminated by the addition of SDS-PAGE loading
buffer and boiling (5 min). Following digestion, products were
resolved by 12% SDS-PAGE and visualized by autoradiography
and phosphorimaging. Arrows indicate the proteolytic fragments
that are diminished upon substitution of hTERT Q169.
Found at: doi:10.1371/journal.pone.0007176.s001 (0.85 MB TIF)
Figure S2 Time-course proteolytic digestion of hTERT WT and
Q169 mutants. RRL containing A, [35S]cysteine-labelled FLAG-
hTERT WT, Q169A, Q169D, or Q169N or B, in vitro
transcribed hTR and [35S]cysteine-labelled FLAG-hTERT WT,
Q169A, Q169D, or Q169N was incubated with 500 ng/mL
chymotrypsin at 30uC for 30 s, 1 min, 2 min, 5 min, 10 min,
15 min, 30 min, and 45 min. 15 mL proteolysis reactions con-
tained approximately equivalent counts of [35S]cysteine-labelled
hTERT. Reactions were terminated by the addition of SDS-
PAGE loading buffer and boiling (5 min). Following digestion,
products were resolved by 12% SDS-PAGE and visualized by
autoradiography and phosphorimaging. Arrows indicate the
proteolytic fragments that are reduced upon substitution of
hTERT Q169.
Found at: doi:10.1371/journal.pone.0007176.s002 (1.31 MB TIF)
Figure S3 Time-course proteolytic digestion of 1–300 hTERT
WT and Q169 mutants. RRL containing A, [35S]cysteine-labelled
1–300 FLAG-hTERT WT, Q169A, Q169D, or Q169N or B, in
vitro transcribed hTR and [35S]cysteine-labelled 1–300 FLAG-
hTERT WT, Q169A, Q169D, or Q169N as incubated at 30uC
with 500 ng/mL chymotrypsin for the indicated time (30 s, 1 min,
2 min, 5 min, 10 min, 15 min, 30 min, and 45 min), terminated
by the addition of SDS-PAGE loading buffer and boiling (5 min),
and resolved by 12% SDS-PAGE. 15 mL proteolysis reactions
contained comparable counts of [35S]cysteine-labelled hTERT.
Following digestion, products were resolved by 12% SDS-PAGE
and visualized by autoradiography and phosphorimaging. Arrows
indicate the proteolytic fragments that are reduced upon
substitution of Q169 in 1–300 hTERT.
Found at: doi:10.1371/journal.pone.0007176.s003 (1.05 MB
DOC)
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